Matthias Götte led new research showing for the first time why the antiviral drug remdesivir is effective against some viruses, including SARS-CoV-2, but not against others — which will help develop broad-spectrum treatments against both existing and new viruses. (Photo: John Ulan)

New study shows why remdesivir works against SARS-CoV-2 but not on other viruses like the flu

Posted on

Understanding interactions between drugs and viruses will be key to building better antivirals and being ready for the next pandemic, says researcher.

Understanding exactly how antiviral drugs interact with viruses at a molecular level will be key to developing the broad-spectrum therapies needed to battle against the SARS-CoV-2 pandemic and get ready to fight the next one, according to a newly published paper in the The Journal of Biological Chemistry….

https://www.ualberta.ca/folio/2022/01/building-better-antivirals.html

Read More Impact Stories

Posted on

B.C. researchers identify gene that fuels aggressive childhood cancers

For patients with neuroblastoma, one of the most common solid tumours in children, disease outcomes can vary widely. Some children [...]
Read more
Posted on

Researchers develop first COVID-19 rapid test for wastewater

McMaster researchers have developed the first COVID rapid test for community wastewater, which will make early warning surveillance of infectious [...]
Read more
Posted on

World’s most comprehensive study on COVID-19 mental health

Study shows limited impact of pandemic on mental health, underlining strength of human resilience. COVID-19 has taken a relatively limited [...]
Read more
View All Impact Stories